Literature DB >> 24056197

Drugs that prevent mouse sleep also block light-induced locomotor suppression, circadian rhythm phase shifts and the drop in core temperature.

P Vivanco1, K M Studholme, L P Morin.   

Abstract

Exposure of mice to a brief light stimulus during their nocturnal active phase induces several simultaneous behavioral or physiological responses, including circadian rhythm phase shifts, a drop in core body temperature (Tc), suppression of locomotor activity and sleep. Each response is triggered by light, endures for a relatively fixed interval and does not require additional light for expression. The present studies address the ability of the psychostimulant drugs, methamphetamine (MA), modafinil (MOD) or caffeine (CAF), to modify the light-induced responses. Drug or vehicle (VEH) was injected at CT11 into constant dark-housed mice then exposed to 5-min 100μW/cm(2) light or no light at CT13. Controls (VEH/Light) showed approximately 60-min phase delays. In contrast, response was substantially attenuated by each drug (only 12-15min delays). Under a 12-h light:12-h dark (LD12:12) photoperiod, VEH/light-treated mice experienced a Tc drop of about 1.3°C coincident with locomotor suppression and both effects were abolished by drug pre-treatment. Each drug elevated activity during the post-injection interval, but there was also evidence for CAF-induced hypoactivity in the dark prior to the photic test stimulus. CAF acutely elevated Tc; MA acutely lowered it, but both drugs reduced Tc during the early dark (ZT12.5-ZT13). The ability of the psychostimulant drugs to block the several effects of light exposure is not the result of drug-induced hyperactivity. The results raise questions concerning the manner in which drugs, activity, sleep and Tc influence behavioral and physiological responses to light.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  12-h light:12-h dark; ANOVA; CAF; DA; DD; DMSO; DSI; Data Sciences International; IP; LD12:12; LED; MA; MOD; SCN; SNK; Student–Newman–Keuls; Tc; VEH; analysis of variance; arousal; caffeine; circadian; constant dark; core body temperature; dimethyl sulfoxide; dopamine; intraperitoneal; light emitting diodes; masking; methamphetamine; modafinil; photosomnolence; suprachiasmatic; suprachiasmatic nucleus; thermoregulation; vehicle

Mesh:

Substances:

Year:  2013        PMID: 24056197      PMCID: PMC3864681          DOI: 10.1016/j.neuroscience.2013.09.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  62 in total

Review 1.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Two components of nocturnal locomotor suppression by light.

Authors:  Lawrence P Morin; Pablo J Lituma; Keith M Studholme
Journal:  J Biol Rhythms       Date:  2010-06       Impact factor: 3.182

3.  Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: dependence on the suprachiasmatic nucleus.

Authors:  Evan P Sleipness; Barbara A Sorg; Heiko T Jansen
Journal:  Brain Res       Date:  2006-12-06       Impact factor: 3.252

Review 4.  Modafinil: a review of neurochemical actions and effects on cognition.

Authors:  Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

5.  Millisecond light pulses make mice stop running, then display prolonged sleep-like behavior in the absence of light.

Authors:  L P Morin; K M Studholme
Journal:  J Biol Rhythms       Date:  2009-12       Impact factor: 3.182

6.  Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action.

Authors:  Heather A Mitchell; James W Bogenpohl; L Cameron Liles; Michael P Epstein; Donna Bozyczko-Coyne; Michael Williams; David Weinshenker
Journal:  Pharmacol Biochem Behav       Date:  2008-07-25       Impact factor: 3.533

7.  Novel neurons in ventral tegmental area fire selectively during the active phase of the diurnal cycle.

Authors:  Alice H Luo; François E Georges; Gary S Aston-Jones
Journal:  Eur J Neurosci       Date:  2008-01       Impact factor: 3.386

8.  Circuit projection from suprachiasmatic nucleus to ventral tegmental area: a novel circadian output pathway.

Authors:  Alice H Luo; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2008-02-05       Impact factor: 3.386

9.  Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil.

Authors:  Wei-Min Qu; Zhi-Li Huang; Xin-Hong Xu; Naomi Matsumoto; Yoshihiro Urade
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

10.  Basal ganglia control of sleep-wake behavior and cortical activation.

Authors:  Mei-Hong Qiu; Ramalingam Vetrivelan; Patrick M Fuller; Jun Lu
Journal:  Eur J Neurosci       Date:  2010-01-25       Impact factor: 3.386

View more
  5 in total

1.  Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Pharmacol Rep       Date:  2016-02-05       Impact factor: 3.024

2.  Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice.

Authors:  Seira Narishige; Mari Kuwahara; Ayako Shinozaki; Satoshi Okada; Yuko Ikeda; Mayo Kamagata; Yu Tahara; Shigenobu Shibata
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

3.  Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions.

Authors:  Deanna M Arble; Joseph Bass; Cecilia Diniz Behn; Matthew P Butler; Etienne Challet; Charles Czeisler; Christopher M Depner; Joel Elmquist; Paul Franken; Michael A Grandner; Erin C Hanlon; Alex C Keene; Michael J Joyner; Ilia Karatsoreos; Philip A Kern; Samuel Klein; Christopher J Morris; Allan I Pack; Satchidananda Panda; Louis J Ptacek; Naresh M Punjabi; Paolo Sassone-Corsi; Frank A Scheer; Richa Saxena; Elizabeth R Seaquest; Matthew S Thimgan; Eve Van Cauter; Kenneth P Wright
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

Review 4.  A Path to Sleep Is through the Eye

Authors:  Lawrence P Morin
Journal:  eNeuro       Date:  2015-03-26

5.  Low β2 Main Peak Frequency in the Electroencephalogram Signs Vulnerability to Depression.

Authors:  Damien Claverie; Chrystel Becker; Antoine Ghestem; Mathieu Coutan; Françoise Camus; Christophe Bernard; Jean-Jacques Benoliel; Frédéric Canini
Journal:  Front Neurosci       Date:  2016-11-02       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.